HEMOSTEMIX INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.05 CAD | +25.00% |
|
0.00% | -28.57% |
| 06-11 | Hemostemix Announces Strategic Manufacturing Partnership with Cytoimmune Therapuetics | CI |
| 06-03 | Hemostemix Inc. announced that it expects to receive CAD 2 million in funding | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| HEMOSTEMIX INC. | Bio Therapeutic Drugs | +25.00% | 0.00% | -28.57% | -58.33% | -94.44% | 3.18M | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- HEM Stock
- Charts Hemostemix Inc.
- Comparison Chart
